HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1- O- beta- glucosyl- N- 2'- hydroxyarachidoyl- 4,8- sphingadienine

dietary monoglucosylceramide; structure in first source

Also Known As:

GHAS cpd

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Inamine, Morihiko: 1 article (12/2005)
2.	Kaneshiro, Tatsuya: 1 article (12/2005)
3.	Kinjo, Tatsuya: 1 article (12/2005)
4.	Morioka, Takamitsu: 1 article (12/2005)
5.	Okada, Tadashi: 1 article (12/2005)
6.	Sugishita, Tomoko: 1 article (12/2005)
7.	Suzui, Masumi: 1 article (12/2005)
8.	Yoshimi, Naoki: 1 article (12/2005)

Related Diseases

1.	Aberrant Crypt Foci 12/01/2005 - "In the present study, we evaluated the preventive efficacy of enriched dietary monoglucosylceramide 1-O-beta-glucosyl-N-2'-hydroxyarachidoyl-4,8-sphingadienine (G(1)CM) on 1,2-dimethylhydrazine (DMH)-induced aberrant crypt foci (ACF) and beta-catenin-accumulated crypt (BCAC) formation in F344 rats during initiation stage. "

Related Drugs and Biologics

1.	beta Catenin
2.	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)
3.	Dimenhydrinate (DMH)